mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.0005 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.002 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |